thiazolidines has been researched along with Parkinson Disease, Secondary in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gleason, WB; Johnson, RL; Khalil, EM; Mishra, RK; Ojala, WH; Pradhan, A | 1 |
Giardiniere, M; Morain, P; Schneider, JS | 1 |
2 other study(ies) available for thiazolidines and Parkinson Disease, Secondary
Article | Year |
---|---|
Synthesis and dopamine receptor modulating activity of substituted bicyclic thiazolidine lactam peptidomimetics of L-prolyl-L-leucyl-glycinamide.
Topics: Animals; Crystallography, X-Ray; Dopamine Agents; Lactams; Male; Models, Molecular; Molecular Mimicry; Molecular Structure; MSH Release-Inhibiting Hormone; Oxidopamine; Parkinson Disease, Secondary; Pyrrolidines; Rats; Rats, Sprague-Dawley; Stereotyped Behavior; Structure-Activity Relationship; Thiazoles; Thiazolidines | 1999 |
Effects of the prolyl endopeptidase inhibitor S 17092 on cognitive deficits in chronic low dose MPTP-treated monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Cognition Disorders; Conditioning, Operant; Discrimination Learning; Dopamine Agents; Indoles; Macaca fascicularis; Male; Parkinson Disease, Secondary; Pattern Recognition, Visual; Prolyl Oligopeptidases; Psychomotor Performance; Serine Endopeptidases; Serine Proteinase Inhibitors; Thiazoles; Thiazolidines | 2002 |